Physician profile
Amanda Vessels
NPI 1194347849
$1,216.19
in general payments reported to CMS, 2019-2025
7 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $165 · 2023: $365 · 2024: $241 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $365.04 | 2023 | Kxl1b-Ce-Marked Kxlsystem, Kxl System (Not Refurbished), Istent Trabecular Micro-Bypass Stent System |
| Bausch & Lomb Americas INC. | $330.69 | 2025 | Infuse, Alden Scleral Zenlens |
| Coopervision INC. | $166.92 | 2024-2025 | Synergeyes Contact Lens, Ortho-K Contact Lens |
| Amgen INC. | $144.50 | 2024 | Tepezza |
| Horizon Therapeutics Plc | $100.29 | 2022 | |
| Oyster Point Pharma, INC. | $64.99 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $43.76 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Vessels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.